Aratana Therapeutics (PETX) Falls: Stock Goes Down 5.9% – Tale of the Tape

This Medical company has seen a flat track record when it comes to current year estimate revisions, as there has been no revision on either side over the past few weeks. The consensus for loss estimate hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

PETX currently has a Zacks Rank # 4 (Sell).

Some better-ranked stocks in the Medical Drugs industry include Blount Endo International plc (ENDP), Hyperion Therapeutics, Inc. (HPTX) and Portola Pharmaceuticals, Inc. (PTLA). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>